Viewing Study NCT00004066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:24 PM
Ignite Modification Date: 2026-01-31 @ 12:31 AM
Study NCT ID: NCT00004066
Status: COMPLETED
Last Update Posted: 2013-03-07
First Post: 1999-12-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Sarcoma View
None Small Intestine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult leiomyosarcoma View
None recurrent adult soft tissue sarcoma View
None small intestine leiomyosarcoma View
None stage IV uterine sarcoma View
None recurrent uterine sarcoma View
None uterine leiomyosarcoma View
None ovarian sarcoma View
None recurrent small intestine cancer View
None stage IV adult soft tissue sarcoma View